Category: Science Explained
A supplement claim built on a study where a compound killed cancer cells in a dish sounds impressive until you ask what dish means. In vitro and in vivo are the two words that expose the gap between a test tube and a human being, and the dose maths that so often breaks the claim.
Category: Science Decoded | Reading time: ~8 min | Level: Intermediate
You have seen the headline in one form or another. A humble kitchen spice, or a berry, or a mushroom, was found to kill cancer cells, or to destroy a virus, or to melt fat. It sounds like a breakthrough hiding in plain sight, and it spreads because it is exciting and because it feels almost too good to be suppressed. Then you read the study, if there even is one, and the word in the methods section is dish.
That single detail changes everything, and the two Latin phrases that capture it, in vitro and in vivo, are among the most useful things a sceptical supplement buyer can learn. They mark the difference between something happening in a controlled little pool of cells and something happening in a living human being, and the gap between those two is where an enormous amount of supplement marketing quietly lives. Here is how to read it.
In vitro is Latin for in glass. It describes experiments carried out on isolated cells, tissues, bacteria or molecules outside a living body, typically in a dish, plate or test tube [1]. A researcher grows cells, adds a compound at a chosen concentration, and watches what happens. In vivo means in a living organism, and covers studies in animals such as mice as well as trials in human participants [1]. The whole living system is present, doing all the things a living system does.
The mechanism sentence that matters is this: a dish contains cells and a chosen chemical, while a body contains digestion, a bloodstream, a liver, target tissues and clearance systems, all of which shape whether a compound ever acts at all [1]. In vitro asks a narrow question, can this compound affect these cells under these conditions. In vivo asks the question people actually care about, does this do something in a living body. Those are not the same question, and confusing them is the root of most overblown claims.
To see why in vitro results so often fail to translate, follow a compound on its real journey. You swallow it. It has to survive stomach acid, be absorbed across the gut wall, and then pass through the liver, which frequently breaks compounds down before they ever reach the general circulation. Whatever survives has to travel through the blood and reach the target tissue at a high enough concentration to act, all while the kidneys and liver work to clear it [4]. Only a fraction of what you took, sometimes a tiny fraction, completes that journey in active form. That fraction is its bioavailability.
A dish skips the entire journey. It applies the compound directly to cells at whatever concentration the researcher chooses [1]. So a compound can look devastating against cells in vitro and yet, in a person, barely reach the bloodstream, or be transformed into something inactive on the way, or never accumulate in the relevant tissue. The dish is not lying about the cells, it is lying by omission about everything a body adds. This is why a plausible mechanism in vitro is a hypothesis, not a result.
The single sharpest reason dish results collapse in people is dose. In vitro studies routinely expose cells to concentrations of a compound far higher than the body could ever reach from a realistic oral dose [2]. The cells see a flood; a person's tissues, at best, see a trickle.
Curcumin, the yellow compound in turmeric, is the textbook case. It does striking things to cells in the dish, which is why it is one of the most studied natural compounds in the world. But it is poorly absorbed, rapidly metabolised and quickly cleared, so blood levels after an oral dose stay very low, and a detailed chemistry review has argued that much of its in vitro activity is misleading for exactly these reasons [2]. The lesson generalises. When you meet a dramatic dish result, the decisive question is whether a human being could ever attain that concentration in the relevant tissue from a sensible dose. Very often the honest answer is no, and the impressive finding never had a route into a real body.
It helps to place animal studies on this map, because they are frequently misread. Animal studies are in vivo, since a living organism is involved, and that makes them genuinely more informative than a dish: an animal captures absorption, metabolism, distribution and whole-body effects that in vitro work cannot [3]. A result that survives from dish to animal has cleared a real hurdle.
But an animal is not a person. Doses are often scaled up, physiology differs, and the artificial disease models used in animals do not always reflect human disease, so a large share of effects seen in mice never appear in humans [3]. The proper hierarchy runs from in vitro, to animal in vivo, to human trials, each step closer to the question that matters. A claim should be graded by how far along that path it has actually travelled, and stopping at mice is a long way from proof in people.
The practical skill is to check the study type before you believe the claim. When a supplement is described as shown to kill cells, inhibit a virus or target a molecule, with no mention of people, that language usually points to a dish or animal study [1]. Honest write-ups signal this with phrases like in laboratory studies, in cell cultures or in test-tube research, and those phrases should lower your confidence, not raise it.
Ask one blunt question of any bold supplement claim: was this tested in people, and what happened? If the only support is cells in a dish or a compound with poor bioavailability, treat the claim as preliminary regardless of how the marketing frames it. This is not cynicism, it is calibration. Dish studies are a legitimate and necessary first step, and the error is not doing them, it is presenting them as if they proved a human benefit. Our guide to how we grade evidence lays out where each study type sits, and our explainer on bioavailability covers why absorption so often breaks the translation from dish to body.
There is a safety angle to the in vitro trap that is easy to miss. A compound presented as powerful on the strength of dish studies can encourage people to take large doses in the belief that more delivers the dramatic effect they read about, when in reality the human effect may be small or absent and the high dose merely adds risk. The gap between in vitro promise and in vivo reality cuts against megadosing, not for it.
This matters most for anyone tempted to self-treat a serious condition with a supplement on the basis of a killed cancer cells headline. Dish evidence is not a reason to substitute a supplement for medical care, and doing so can be genuinely harmful. Preliminary means unproven, and unproven is exactly the wrong footing for a high-stakes decision.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
The in vitro versus in vivo distinction is close to the centre of how we grade anything. A dish result tells us a mechanism is worth exploring; only in vivo evidence, and ideally human trials, tells us whether an ingredient does something for a person. We grade dish studies below human trials not to dismiss them but to place them correctly on the road from hypothesis to proof, and we try to say plainly when a claim has only travelled as far as cells.
If you want to go further, our explainer on how we grade evidence shows the full hierarchy, our piece on bioavailability explains why so much dish activity never reaches the body, and our guide to systematic reviews covers how human evidence gets pooled and weighed. You can also browse the Remedy Library to see how we describe what an ingredient has, and has not, actually been shown to do in people.
1. National Center for Complementary and Integrative Health (2023). Know the science: study types. Government research guidance explaining in vitro, animal and human study designs. 2. Nelson KM, Dahlin JL, Bisson J, et al. (2017). The essential medicinal chemistry of curcumin. Journal of Medicinal Chemistry, 60(5):1620-1637. PMID 28074653. Review arguing that curcumin's poor bioavailability makes much of its in vitro activity misleading. 3. Van Norman GA (2019). Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC: Basic to Translational Science, 4(7):845-854. PMID 31998852. Review of why animal in vivo results often fail to translate to people. 4. US Food and Drug Administration (2023). The drug development process. Regulatory guidance on the path from laboratory studies to human clinical trials.
In vitro is Latin for in glass. It describes experiments done outside a living organism, on isolated cells, tissues, bacteria or molecules, typically in a dish, plate or test tube. A researcher might grow human cells in a dish and add a plant compound to see what happens. These studies are fast, cheap and useful for exploring how something might work at a basic level. What they cannot show is whether the same thing happens in a whole living body, because a dish leaves out digestion, the bloodstream, the liver and everything else that shapes a real effect.
In vivo means in a living organism. An in vivo study tests something in an actual living body, whether an animal such as a mouse or a human participant in a trial. Because the whole organism is involved, in vivo studies capture how a substance is absorbed, distributed, broken down and cleared, and whether it produces a real effect and real side effects. Human in vivo studies, especially randomised controlled trials, are far closer to the question most people care about, does this work in people, than any dish experiment can be.
Because a dish is missing almost everything a body does. When you swallow a compound it has to survive stomach acid, be absorbed through the gut, pass through the liver where it is often broken down, and then reach a target tissue at a high enough concentration to act, all while the body works to clear it. A dish skips all of that, exposing cells directly to a chosen concentration. So a compound can look powerful in vitro yet barely reach the bloodstream in a person, or be transformed into something inactive on the way. The dish answers a narrow mechanistic question, not the human one.
It is the mismatch between the concentration that works in a dish and what is realistically achievable in a human body. In vitro studies often expose cells to concentrations of a compound far higher than the body could ever reach from a normal oral dose. A famous example is curcumin from turmeric, which does striking things in the dish but is poorly absorbed and rapidly cleared, so blood levels stay very low. When you see a dramatic in vitro result, the key question is whether a person could ever attain that concentration in the relevant tissue, and often the answer is no.
Not at all. They are a vital first step. In vitro work is how researchers explore mechanisms, screen many compounds quickly, and decide what is worth testing in living systems. The problem is not doing in vitro studies, it is treating them as if they proved a human benefit. A dish result is a hypothesis about what might happen in a body, not evidence that it does. Good science moves from in vitro to animal in vivo to human trials, and a claim should be graded by how far along that path it has actually travelled.
Look for tell-tale phrasing and check the study type. Words like shown to kill cells, inhibits, or targets, without mention of people, often signal a dish or animal study. Phrases such as in laboratory studies, in cell cultures, or in test-tube research are honest flags that the work was in vitro. If a bold claim about a supplement cannot point to human trials and instead leans on studies of cells or isolated molecules, treat it as preliminary. The honest question to ask is simply, was this tested in people, and if so, what happened.
Animal studies are in vivo, because a living organism is involved. They sit between dish studies and human trials in how much they tell you. An animal captures absorption, metabolism and whole-body effects that a dish cannot, which makes it more informative than in vitro work. But animals are not people: doses, physiology and disease models differ, and many effects seen in mice never appear in humans. So animal evidence is a meaningful step up from a dish and still well short of proof in people.
On its own, no, and it is worth being sceptical of how it is framed. Killing cancer cells almost always refers to an in vitro study where cells were exposed directly to the compound in a dish, often at concentrations no human could reach by swallowing it. That is a mechanistic starting point, not evidence that the supplement does anything against cancer in a person, and presenting it as if it did is one of the most common misleading moves in supplement marketing. The claim you should look for is whether it helped actual people in a trial.
Because the two answer different questions. A dish study can show a plausible mechanism, but it cannot show that a realistic dose reaches the right tissue in a living body and produces a benefit, which is the question that matters for a person deciding whether to take something. Grading in vitro evidence below human trials is not dismissing it, it is placing it correctly on the path from hypothesis to proof. A compound with only dish evidence is interesting and unproven, and honest grading says so.
Not reliably. A sensible mechanism in a dish is a reason to test further, not a reason to expect a human effect, because the body can defeat a mechanism in several ways: poor absorption, rapid breakdown, failure to reach the target tissue, or compensating systems that blunt the effect. The history of medicine is full of compounds that worked beautifully in vitro and failed in people. A plausible mechanism raises a hypothesis; only in vivo evidence, ideally human trials, tests whether the hypothesis holds.